Sudhin Biopharma Company

Superior, CO

UEI
YWLVHDAGLHD3
CAGE
79MZ5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Manufacturer of Goods
  • Subcontinent Asian (Asian-Indian) American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
685 E Heartstrong St, Superior, CO 80027, USA
Website
sudhinbio.com
Founded
2014
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

SBA capabilities narrative

recombinant mammalian and microbial cell cultures, perfusion bioreactor cultures, clarification of cell culture broth, harvesting of stem cells, stem cell growth and differentiation bioreactor, separation of single cells from cell clusters, retention of cells and cell clusters during media exchanges.

Quick answers

Is Sudhin Biopharma Company registered in SAM.gov?

Yes. Sudhin Biopharma Company's SAM.gov registration is active through November 13, 2026.

What is Sudhin Biopharma Company's most recent federal award?

Sudhin Biopharma Company's most recent federal grant award is Sbir phase i: novel compact cell settlers for high cell density perfusion cultures of mammalian cells (1648370), from National Science Foundation, on December 1, 2016.

On GovTribe

See Sudhin Biopharma Company's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors